Stoke Therapeutics's market cap is currently $1.25B. The company's EPS TTM is $-0.4; its P/E ratio is 27.16; Stoke Therapeutics is scheduled to report earnings on August 12, 2025, and the estimated EPS forecast is $-0.58. See an overview of income statement, balance sheet, and cash flow financials.
